Abstract
Gap junction is a cell-cell communication junction type found in virtually all mammalian epithelia and endothelia and provides the necessary “signals” to coordinate physiological events to maintain the homeostasis of an epithelium and/or endothelium under normal physiological condition and following changes in the cellular environment (e.g., stimuli from stress, growth, development, inflammation, infection). Recent studies have illustrated the significance of this junction type in the maintenance of different blood-tissue barriers, most notably the blood-brain barrier and blood-testis barrier, which are dynamic ultrastructures, undergoing restructuring in response to stimuli from the environment. In this chapter, we highlight and summarize the latest findings in the field regarding how changes at the gap junction, such as the result of a knock-out, knock-down, knock-in, or gap junction inhibition and/or its activation via the use of inhibitors and/or activators, would affect the integrity or permeability of the blood-tissue barriers. These findings illustrate that much research is needed to delineate the role of gap junction in the blood-tissue barriers, most notably its likely physiological role in mediating or regulating the transport of therapeutic drugs across the blood-tissue barriers.
Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Alberts B, Johnson A, Lewis J et al. Molecular Biology of the Cell. 4th ed. New York: Garland Science; 2002.
Mese G, Richard G, White TW. Gap junctions: basic structure and function. J Invest Dermatol 2007; 127:2516–2524.
Dbouk HA, Mroue RM, El-Sabban ME et al. Connexins: a myriad of functions extending beyond assembly of gap junction channels. Cell Commun Signal 2009; 7:4.
Sáez JC, Berthoud VM, Brañes MC et al. Plasma membrane channels formed by connexins: their regulation and functions. Physiol Rev 2003; 83:1359–1400.
Shestopalova VI, Panchinc Y. Pannexins and gap junction protein diversity. Cell Mol Life Sci 2008; 65:376–394.
Stout C, Goodenough DA, Paul DL. Connexins: functions without junctions. Curr Opin Cell Biol 2004; 16:507.
D’hondt C, Ponsaerts R, De Smedt H et al. Pannexins, distant relatives of the connexin family with specific cellular functions? Bioessays 2009; 31:953–974.
Yen MR, Saier MH Jr. Gap junctional proteins of animals: The innexin/pannexin superfamily. Prog Biophys Mol Biol 2007; 94:5–14.
Baranova A, Ivanov D, Petrash N et al. The mammalian pannexin family is homologous to the invertebrate innexin gap junction proteins. Genomics 2004; 83:706–716.
Fawcett DW. Intercellular bridges. Exp Cell Res 1961; 8:174–187.
Dym M, Fawcett DW. Further observations on the numbers of spermatogonia, spermatocytes and spermatids connected by intercellular bridges in the mammalian testis. Biol Reprod 1971; 4:195–215.
Kumar NM, Gilula NB. The gap junction communication channel. Cell 1996; 84:381–388.
Pahujaa M, Anikin M, Goldberg GS. Phosphorylation of connexin43 induced by Src: regulation of gap junctional communication between transformed cells. Exp Cell Res 2007; 313:4083–4090.
Plum A, Hallas G, Magin T et al. Unique and shared functions of different connexins in mice. Curr Biol 2000; 10:1083–1091.
Winterhager E, Pielensticker N, Freyer J et al. Replacement of connexin43 by connexin26 in transgenic mice leads to dysfunctional reproductive organs and slowed ventricular conduction in the heart. BMC Dev Biol 2007; 7:26.
Söhl G, Willecke K. An update on connexin genes and their nomenclature in mouse and man. Cell Adhes Commun 2003; 10:173–180.
Hervé JC, Derangeon M, Bahbouhi B et al. The connexin turnover, an important modulating factor of the level of cell-to-cell junctional communication: comparison with other integral membrane proteins. J Membr Biol 2007; 217:21–33.
Laird DW. Life cycle of connexins in health and disease. Biochem J 2006; 394:527–543.
Koval M. Pathways and control of connexin oligomerization. Trends Cell Biol 2006; 16:159–166.
Martin PEM, Blundell G, Ahmad S et al. Multiple pathways in the trafficking and assembly of connexin 26, 32 and 43 into gap junction intercellular communication channels. J Cell Sci 2001; 114:3845–3855.
Das Sarma J, Meyer RA, Wang F et al. Multimeric connexin interactions prior to the trans-Golgi network. J Cell Sci 2001; 114:4013–4024.
Yum SW, Zhang J, Valiunas V et al. Human connexin26 and connexin30 form functional heteromeric and heterotypic channels. Am J Physiol Cell Physiol 2007; 293:C1032–C1048.
Olk S, Zoidl G, Dermietzel R. Connexins, cell motility and the cytoskeleton. Cell Motil Cytoskeleton 2009; 66:1000–1016.
Shaw RM, Fay AJ, Puthenveedu MA et al. Microtubule plus-end-tracking proteins target gap junctions directly from the cell interior to adherens junctions. Cell 2007; 128:547–560.
González D, Gómez-Hernández JM, Barrio LC. Molecular basis of voltage dependence of connexin channels: an integrative appraisal. Prog Biophys Mol Biol 2007; 94:66–106.
Moreno AP, Lau AF. Gap junction channel gating modulated through protein phosphorylation. Prog Biophys Mol Biol 2007; 94:107–119.
King TJ, Lampe PD. Temporal regulation of connexin phosphorylation in embryonic and adult tissues. Biochim Biophys Acta 2005; 1719:24–35.
Solan JL, Fry MD, TenBroek EM et al. Connexin43 phosphorylation at S368 is acute during S and G2/M and in response to protein kinase C activation. J Cell Sci 2003; 116:2203–2211.
Simpson I, Rose B, Loewenstein WR. Size limit of molecules permeating the junctional membrane channels. Science 1977; 195:294–296.
Loewenstein WR. Junctional intercellular communication: the cell-to-cell membrane channel. Physiol Rev 1981; 61:829–913.
Harris AL. Connexin channel permeability to cytoplasmic molecules. Prog Biophys Mol Biol 2007; 94:120–143.
Weber PA, Chang HC, Spaeth KE et al. The permeability of gap junction channels to probes of different size is dependent on connexin composition and permeant-pore affinities. Biophys J 2004; 87:958–973.
Goldberg GS, Lampe PD, Nicholson BJ. Selective transfer of endogenous metabolites through gap junctions composed of different connexins. Nat Cell Biol 1999; 1:457–459.
Kanaporis G, Mese G, Valiuniene L et al. Gap junction channels exhibit connexin-specific permeability to cyclic nucleotides. J Gen Physiol 2008; 131:293–305.
Elfgang C, Eckert R, Lichtenberg-Fraté H et al. Specific permeability and selective formation of gap junction channels in connexin-transfected HeLa cells. J Cell Biol 1995; 129:805–817.
Goldberg GS, Moreno AP, Lampe PD. Gap junctions between cells expressing connexin 43 or 32 show inverse permselectivity to adenosine and ATP. J Biol Chem 2002; 277:36725–36730.
Valiunas V, Polosina YY, Miller H et al. Connexin-specific cell-to-cell transfer of short interfering RNA by gap junctions. J Physiol (Lond) 2005; 568:459–468.
Bevans CG, Kordel M, Rhee SK et al. Isoform composition of connexin channels determines selectivity among second messengers and uncharged molecules. J Biol Chem 1998; 273:2808–2816.
Martínez AD, Hayrapetyan V, Moreno AP et al. Connexin43 and connexin45 form heteromeric gap junction channels in which individual components determine permeability and regulation. Circ Res 2002; 90:1100–1107.
Evans WH, Boitano S. Connexin mimetic peptides: specific inhibitors of gap-junctional intercellular communication. Biochem Soc Trans 2001; 29:606–612.
Wang J, Ma M, Locovei S et al. Modulation of membrane channel currents by gap junction protein mimetic peptides: size matters. Am J Physiol Cell Physiol 2007; 293:C1112–C1119.
Neyton J, Trautmann A. Single-channel currents of an intercellular junction. Nature 1985; 317:331–335.
El-Fouly MH, Trosko JE, Chang CC. Scrape-loading and dye transfer: a rapid and simple technique to study gap junctional intercellular communication. Exp Cell Res 1987; 168:422–430.
Risley MS, Tan IP, Farrell J. Gap junctions with varied permeability properties establish cell-type specific communication pathways in the rat seminiferous epithelium. Biol Reprod 2002; 67:945–952.
Goldberg GS, Bechberger JF, Naus CC. A preloading method of evaluating gap junctional communication by fluorescent dye transfer. Biotechniques 1995; 18:490–497.
Wade MH, Trosko JE, Schindler M. A fluorescence photobleaching assay of gap junction-mediated communication between human cells. Science 1986; 232:525–528.
Bloomfield SA, Völgyi B. The diverse functional roles and regulation of neuronal gap junctions in the retina. Nat Rev Neurosci 2009; 10:495–506.
Pointis G, Gilleron J, Carette D et al. Physiological and physiopathological aspects of connexins and communicating gap junctions in spermatogenesis. Philos Trans R Soc Lond B Biol Sci 2010; 365:1607–1620.
Nattel S, Maguy A, Le Bouter S et al. Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction and atrial fibrillation. Physiol Rev 2007; 87:425–456.
Hervé JC, Bourmeyster N, Sarrouilhe D et al. Gap junctional complexes: from partners to functions. Prog Biophys Mol Biol 2007; 94:29–65.
Derangeona M, Sprayb DC, Bourmeystera N et al. Reciprocal influence of connexins and apical junction proteins on their expressions and functions. Biochim Biophys Acta 2009; 1788:768–778.
Toyofuku T, Yabuki M, Otsu K et al. Direct association of the gap junction protein connexin-43 with ZO-1 in cardiac myocytes. J Biol Chem 1998; 273:12725–12731.
Singh D, Solan JL, Taffet SM et al. Connexin 43 interacts with zona occludens-1 and-2 proteins in a cell cycle stage-specific manner. J Biol Chem 2005; 280:30416–30421.
Toyofuku T, Akamatsu Y, Zhang H et al. c-Src regulates the interaction between connexin-43 and ZO-1 in cardiac myocytes. J Biol Chem 2001; 276:1780–1788.
Gilleron J, Fiorini C, Carette D et al. Molecular reorganization of C×43, ZO-1 and Src complexes during the endocytosis of gap junction plaques in response to a nongenomic carcinogen. J Cell Sci 2008; 121:4069–4078.
Postma FR, Hengeveld T, Alblas a et al. Acute loss of cell-cell communication caused by G protein-coupled receptors: a critical role for c-Src. J Cell Biol 1998; 140:1199–1209.
Giepmans BNG, Hengeveld T, Postma FR et al. Interaction of c-Src with gap junction protein connexin-43. J Biol Chem 2001; 276:8544–8549.
Meyer RA, Laird DW, Revel JP et al. Inhibition of gap junction and adherens junction assembly by connexin and A-CAM antibodies. J Cell Biol 1992; 119:179–189.
Wei CJ, Francis R, Xu X et al. Connexin43 associated with an N-cadherin-containing multiprotein complex is required for gap junction formation in NIH3T3 cells. J Biol Chem 2005; 280:19925–19936.
Li MWM, Mruk DD, Lee WM et al. Connexin 43 and plakophilin-2 as a protein complex that regulates blood-testis barrier dynamics. Proc Natl Acad Sci USA 2009; 106:10213–10218.
Basso C, Corrado D, Marcus FI et al. Arrhythmogenic right ventricular cardiomyopathy. Lancet 2009; 373:1289–1300.
Kaplan SR, Gard JJ, Protonotarios N et al. Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease). Heart Rhythm 2004; 1:3–11.
Fidler LM, Wilson GJ, Liu F et al. Abnormal connexin43 in arrhythmogenic right ventricular cardiomyopathy caused by plakophilin-2 mutations. J Cell Mol Med 2008; 13:4219–4228.
Oxford EM, Musa H, Maass K et al. Connexin43 remodeling caused by inhibition of plakophilin-2 expression in cardiac cells. Circ Res 2007; 101:703–711.
Russell L. Desmosome-like junctions between Sertoli and germ cells in the rat testis. Am J Anat 1977; 148:301–312.
Vogl AW, Vaid KS, Guttman JA. The Sertoli cell cytoskeleton. Adv Exp Med Biol 2008; 636:186–211.
Szöllösi D. Desmosomes: their occurrence between adjacent primary oocytes in polyovular follicles in the rabbit. Cell Tissue Res 1978; 191:115–119.
Anderson E, Beams HW. Cytological observations on the fine structure of the guinea pig ovary with special reference to the oogonium, primary oocyte and associated follicle cells. J Ultrastruct Res 1960; 3:432–446.
Vinores SA. Assessment of blood-retinal barrier integrity. Histol Histopathol 1995; 10:141–154.
Bechmann I, Galea I, Perry VH. What is the blood-brain barrier (not)? Trends Immunol 2007; 28:5–11.
Hornof M, Toropainen E, Urtti A. Cell culture models of the ocular barriers. Eur J Pharm Biopharm 2005; 60:207–225.
Krüger O, Plum A, Kim JS et al. Defective vascular development in connexin 45-deficient mice. Development 2000; 127:4179–4193.
Simon AM, McWhorter AR. Vascular abnormalities in mice lacking the endothelial gap junction proteins connexin37 and connexin40. Dev Biol 2002; 251:206–220.
Nagasawa K, Chiba H, Fujita H et al. Possible involvement of gap junctions in the barrier function of tight junctions of brain and lung endothelial cells. J Cell Physiol 2006; 208:123–132.
Alonso A, Reinz E, Jenne JW et al. Reorganization of gap junctions after focused ultrasound blood-brain barrier opening in the rat brain. J Cereb Blood Flow Metab 2010; 30:1394–1402.
Wong EWP, Mruk DD, Cheng CY. Biology and regulation of ectoplasmic specialization, an atypical adherens junction type, in the testis. Biochim Biophys Acta 2008; 1778:692–708.
Cheng CY, Mruk DD. A local autocrine axis in the testes that regulate spermatogenesis. Nat Rev Endocrinol 2010; 6:380–395.
Pelletier RM, Byers SW. The blood-testis barrier and Sertoli cell junctions: structural considerations. Microsc Res Tech 1992; 20:3–33.
Brehm R, Zeiler M, Ruttinger C et al. A Sertoli cell-specific knockout of connexin43 prevents initiation of spermatogenesis. Am J Pathol 2007; 171:19–31.
Sridharan S, Simon L, Meling DD et al. Proliferation of adult sertoli cells following conditional knockout of the gap junctional protein GJA1 (connexin 43) in mice. Biol Reprod 2007; 76:804–812.
Walker WH. Molecular mechanisms controlling Sertoli cell proliferation and differentiation. Endocrinology 2003; 144:3719–3721.
Lie PPY, Cheng CY, Mruk DD. Crosstalk between desmoglein-2/desmocollin-2/Src kinase and coxsackie and adenovirus receptor/ZO-1 protein complexes, regulates blood-testis barrier dynamics. Int J Biochem Cell Biol 2010; 42:975–986.
R ichard G, Smith LE, Bailey RA et al. Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis. Nat Genet 1998; 20:366–369.
Lamartine J, Munhoz Essenfelder G, Kibar Z et al. Mutations in GJB6 cause hidrotic ectodermal dysplasia. Nat Med 2000; 26:142–144.
Macari F, Landau M, Cousin P et al. Mutation in the gene for connexin 30.3 in a gamily with erythrokeratodermia variabilis. Am J Hum Genet 2000; 67:1296–1301.
D’Adamo P, Guerci VI, Fabretto A et al. Does epidermal thickening explain GJB2 high carrier frequency and heterozygote advantage? Eur J Hum Genet 2009; 17:284–286.
Meyer CG, Amedofu GK, Brandner JM et al. Selection for deafness? Nat Med 2002; 8:1332–1333.
Djalilian AR, McGaughey D, Patel S et al. Connexin 26 regulates epidermal barrier and wound remodeling and promotes psoriasiform response. J Clin Invest 2006; 116:1243–1253.
Man YKS, Trolove C, Tattersall D et al. A deafness-associated mutant human connexin 26 improves the epithelial barrier in vitro. J Membr Biol 2007; 218:29–37.
Maass K, Ghanem A, Kim JS et al. Defective epidermal barrier in neonatal mice lacking the C-terminal region of connexin43. Mol Biol Cell 2004; 15:4597–4608.
Kretz M, Euwens C, Hombach S et al. Altered connexin expression and wound healing in the epidermis of connexin-deficient mice. J Cell Sci 2003; 116:3443–3452.
Qiu C, Coutinho P, Frank S et al. Targeting connexin43 expression accelerates the rate of wound repair. Curr Biol 2003; 13:1697–1703.
Guttman JA, Lin AEJ, Li Y et al. Gap junction hemichannels contribute to the generation of diarrhoea during infectious enteric disease. Gut 2010; 59:218–226.
Naus CC, Laird DW. Implications and challenges of connexin connections to cancer. Nat Rev Cancer 2010; 10:435–441.
Elzarrad MK, Haroon A, Willecke K et al. Connexin-43 upregulation in micrometastases and tumor vasculature and its role in tumor cell attachment to pulmonary endothelium. BMC Med 2008; 6:20.
Mesnil M, Piccoli C, Tiraby G et al. Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins. Proc Natl Acad Sci USA 1996; 93:1831–1835.
Eugenin EA, Berman JW. Gap junctions mediate human immunodeficiency virus-bystander killing in astrocytes. J Neurosci 2007; 27:12844–12850.
Cronin M, Anderson PN, Cook JE et al. Blocking connexin43 expression reduces inflammation and improves functional recovery after spinal cord injury. Mol Cell Neurosci 2008; 39:152–160.
Azzam EI, de Toledo SM, Little JB. Direct evidence for the participation of gap junctionmediated intercellular communication in the transmission of damage signals from a-particle irradiated to nonirradiated cells. Proc Natl Acad Sci USA 2001; 98:473–478.
Bhabra G, Sood A, Fisher B et al. Nanoparticles can cause DNA damage across a cellular barrier. Nat Nanotechnol 2009; 4:876–883.
Müller A, Schaefer T, Linke W et al. Actions of the antiarrhythmic peptide AAP10 on intercellular coupling. Naunyn Schmiedebergs Arch Pharmacol 1997; 356:76–82.
Mancuso M, Pasquali E, Leonardi S et al. Oncogenic bystander radiation effects in Patched heterozygous mouse cerebellum. Proc Natl Acad Sci USA 2008; 105:12445–12450.
Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74:1124–1136.
Dahl NA, Balfour WM. Prolonged anoxia survival due to anoxia pre-exposure: brain ATP, lactate and pyruvate. Am J Physiol 1964; 207:452–456.
Lin JHC, Lou N, Kang N et al. A central role of connexin 43 in hypoxic preconditioning. J Neurosci 2008; 28:681–695.
Schwanke U, Konietzka I, Duschin A et al. No ischemic preconditioning in heterozygous connexin43-deficient mice. Am J Physiol Heart Circ Physiol 2002; 283:H1740–H1742.
Miura T, Miki T, Yano T. Role of the gap junction in ischemic preconditioning in the heart. Am J Physiol Heart Circ Physiol 2010; 298:1115–1125.
Prise KM, O’Sullivan JM. Radiation-induced bystander signalling in cancer therapy. Nat Rev Cancer 2009; 9:351–360.
Moolten FL, Wells JM. Curability of Tumors Bearing Herpes Thymidine Kinase Genes Transfered by Retroviral Vectors. J Natl Cancer Inst 1990; 82:297–300.
Trepel M, Stoneham CA, Eleftherohorinou H et al. A heterotypic bystander effect for tumor cell killing after adeno-associated virus/phage-mediated, vascular-targeted suicide gene transfer. Mol Cancer Ther 2009; 8:2383–2391.
Zhang H, Dornadula G, Beumont M et al. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. N Engl J Med 1998; 339:1803–1809.
Marcelin AG, Tubiana R, Lambert-Niclot S et al. Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma. AIDS 2008; 22:1677–1679.
Paznekas WA, Boyadjiev SA, Shapiro RE et al. Connexin 43 (GJA1) mutations cause the pleiotropic phenotype of oculodentodigital dysplasia. Am J Hum Genet 2003; 72:408–418.
Dasguptaa C, Martinezb AM, Zuppanb CW et al. Identification of connexin43 (a1) gap junction gene mutations in patients with hypoplastic left heart syndrome by denaturing gradient gel electrophoresis (DGGE). Mutat Res 2001; 479:173–186.
Yang JJ, Huang SH, Chou KH et al. Identification of mutations in members of the connexin gene family as a cause of nonsyndromic deafness in Taiwan. Audiol Neurootol 2007; 12:198–208.
Vaidya D, Tamaddon HS, Lo CW et al. Null mutation of connexin43 causes slow propagation of ventricular activation in the late stages of mouse embryonic development. Circ Res 2001; 88:1196–1202.
Reaume AG, de Sousa P, Kulkarni S et al. Cardiac malformation in neonatal mice lacking connexin43. Science 1995; 267:1831–1834.
Lecandaa F, Warlowa PM, Sheikha S et al. Connexin43 deficiency causes delayed ossification, craniofacial abnormalities and osteoblast dysfunction. J Cell Biol 2000; 151:931–944.
Mackay D, Ionides A, Kibar Z et al. Connexin46 mutations in autosomal dominant congenital cataract. Am J Hum Genet 1999; 64:1357–1364.
Gong X, Li E, Klier G et al. Disruption of a3 connexin gene leads to proteolysis and cataractogenesis in mice. Cell 1997; 91:833–843.
Simon AM, Goodenough DA, Li E et al. Female infertility in mice lacking connexin 37. Nature 1997; 385:525–529.
Gollob MH, Jones DL, Krahn AD et al. Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation. N Engl J Med 2006; 354:2677–2688.
Tamaddon HS, Vaidya D, Simon AM et al. High-resolution optical mapping of the right bundle branch in connexin40 knockout mice reveals slow conduction in the specialized conduction system Circ Res 2000; 87:929–936.
van Rijen HVM, van Veen TAB, van Kempen MJA et al. Impaired conduction in the bundle branches of mouse hearts lacking the gap junction protein connexin40. Circ Res 2001; 103:1591–1598.
Shiels A, Mackay D, Ionides A et al. A missense mutation in the human connexin50 gene (GJA8) underlies autosomal dominant “zonular pulverulent” cataract, on chromosome 1q. Am J Hum Genet 1998; 62:526–532.
White TW, Goodenough DA, Paul DL. Targeted ablation of connexin50 in mice results in microphthalmia and zonular pulverulent cataracts. J Cell Biol 1998; 143:815–825.
Shelley J, Dedek K, Schubert T et al. Horizontal cell receptive fields are reduced in connexin57-deficient mice. Eur J Neurosci 2006; 23:3176–3186.
Fairweather N, Bell C, Cochrane S et al. Mutations in the connexin 32 gene in X-linked dominant Charcot-Marie-Tooth disease (CMTX1) Hum Mol Genet 1994; 3:29–34.
Nelis E, Van Broeckhoven C, De Jonghe P et al. Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study. Eur J Hum Genet 1996; 4:25–33.
Nelles E, Bützler C, Jung D et al. Defective propagation of signals generated by sympathetic nerve stimulation in the liver of connexin32-deficient mice. Proc Natl Acad Sci USA 1996; 93:9565–9570.
Temme A, Buchmann A, Gabriel HD et al. High incidence of spontaneous and chemically induced liver tumors in mice deficient for connexin32. Curr Biol 1997; 7:713–716.
Sutor B, Schmolke C, Teubner B et al. Connexin 47 (cx47)-deficient mice with enhanced green fluorescent protein reporter gene reveal predominant oligodendrocytic expression of cx47 and display vacuolized myelin in the CNS. Cereb Cortex 2000; 10:684–697.
Gabriel H, Kupsch P, Sudendey J et al. Mutations in the connexin26/GJB2 gene are the most common event in nonsyndromic hearing loss among the German population. Hum Mutat 2001; 17:521–522.
Kelsell DP, Dunlop J, Stevens HP et al. Connexin 26 mutations in hereditary nonsyndromic sensorineural deafness. Nature 1997; 387:80–83.
Richard G, Rouan F, Willoughby CE et al. Missense mutations in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis-ichthyosis-deafness syndrome. Am J Hum Genet 2002; 70:1341–1348.
Maestrini E, Korge BP, Ocaña-Sierra J et al. A missense mutation in connexin26, D66H, causes mutilating keratoderma with sensorineural deafness (Vohwinkel’s syndrome) in three unrelated families. Hum Mol Genet 1999; 8:1237–1243.
Gabriel HD, Jung D, Bützler C et al. Transplacental uptake of glucose is decreased in embryonic lethal connexin26-deficient mice. J Cell Biol 1998; 140:1453–1461.
Liu XZ, Xia XJ, Xu LR et al. Mutations in connexin31 underlie recessive as well as dominant nonsyndromic hearing loss. Hum Mol Genet 2000; 9:63–67.
Xia J, Liu C, Tang B et al. Mutations in the gene encoding gap junction protein b-3 associated with autosomal dominant hearing impairment. Nat Genet 1998; 20:370–373.
Plum A, Winterhager E, Pesch J et al. Connexin31-deficiency in mice causes transient placental dysmorphogenesis but does not impair hearing and skin differentiation. Dev Biol 2001; 231:334–347.
del Castillo I, Villamar M, Moreno-Pelayo MA et al. A deletion involving the connexin 30 gene in nonsyndromic hearing impairment. N Engl J Med 2002; 346:243–249.
Teubner B, Michel V, Pesch J et al. Connexin30 (Gjb6)-deficiency causes severe hearing impairment and lack of endocochlear potential. Hum Mol Genet 2003; 12:13–21.
Dere E, De Souza-Silva MA, Frisch C et al. Connexin30-deficient mice show increased emotionality and decreased rearing activity in the open-field along with neurochemical changes. Eur J Neurosci 2003; 18:629–638.
Kumai M, Nishii K, Nakamura K et al. Loss of connexin45 causes a cushion defect in early cardiogenesis. Development 2000; 127:3501–3512.
U hlenberg B, Schuelke M, Rüschendorf F et al. Mutations in the gene encoding gap junction protein a12 (connexin 46.6) cause Pelizaeus-Merzbacher-like disease. Am J Hum Genet 2004; 75:251–260.
Odermatt B, Wellershaus K, Wallraff A et al. Connexin 47 (C×47)-deficient mice with enhanced green fluorescent protein reporter gene reveal predominant oligodendrocytic expression of C×47 and display vacuolized myelin in the CNS. J Neurosci 2003; 23:4549–4559.
Wang WH, Yang JJ, Lin YC et al. Identification of novel variants in the C×29 gene of nonsyndromic hearing loss patients using buccal cells and RFLP method. Audiol Neurootol 2010; 15:81–87.
Güldenagel M, Ammermüller J, Feigenspan A et al. Visual transmission deficits in mice with targeted disruption of the gap junction gene connexin36. J Neurosci 2001; 21:6036–6044.
Kreuzberg MM, Schrickel JW, Ghanem A et al. Connexin30.2 containing gap junction channels decelerate impulse propagation through the atrioventricular node. Proc Natl Acad Sci USA 2006; 103:5959–5964.
Go M, Kojima T, Takano K et al. Connexin 26 expression prevents down-regulation of barrier and fence functions of tight junctions by Na+/K+-ATPase inhibitor ouabain in human airway epithelial cell line Calu-3. Exp Cell Res 2006; 312:3847–3856.
Morita H, Katsuno T, Hoshimoto A et al. Connexin 26-mediated gap junctional intercellular communication suppresses paracellular permeability of human intestinal epithelial cell monolayers. Exp Cell Res 2004; 298:1–8.
Nhieu GTV, Clair C, Bruzzone R et al. Connexin-dependent inter-cellular communication increases invasion and dissemination of Shigella in epithelial cells. Nat Cell Biol 2003; 5:720–726.
Cohen-Salmon M, Regnault B, Cayet N et al. Connexin30 deficiency causes instrastrial fluid-blood barrier disruption within the cochlear stria vascularis. Proc Natl Acad Sci USA 2007; 104:6229–6234.
Kojima T, Sawada N, Chiba H et al. Induction of tight junctions in human connexin 32 (hC×32)-transfected mouse hepatocytes: connexin 32 interacts with occludin. Biochem Biophys Res Commun 1999; 266:222–229.
Kojima T, Spray DC, Kokai Y et al. C×32 formation and/or C×32-mediated intercellular communication induces expression and function of tight junctions in hepatocytic cell line. Exp Cell Res 2002; 276:40–51.
Le ACN, Musil LS. Normal differentiation of cultured lens cells after inhibition of gap junction-mediated intercellular communication. Dev Biol 1998; 204:80–96.
Eugenin EA, Branes MC, Berman JW et al. TNF-α plus IFN-γ induce connexin43 expression and formation of gap junctions between human monocytes/macrophages that enhance physiological responses. J Immunol 2003; 170:1320–1328.
Leaphart CL, Qureshilow F, Cetinlow S et al. Interferon-γ inhibits intestinal restitution by preventing gap junction communication between enterocytes. Gastroenterology 2007; 132:2395–2411.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Landes Bioscience and Springer Science+Business Media
About this chapter
Cite this chapter
Li, M.W.M., Mruk, D.D., Cheng, C.Y. (2013). Gap Junctions and Blood-Tissue Barriers. In: Cheng, C.Y. (eds) Biology and Regulation of Blood-Tissue Barriers. Advances in Experimental Medicine and Biology, vol 763. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4711-5_13
Download citation
DOI: https://doi.org/10.1007/978-1-4614-4711-5_13
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-4710-8
Online ISBN: 978-1-4614-4711-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)